Britt Christensen

2.6k total citations
90 papers, 1.2k citations indexed

About

Britt Christensen is a scholar working on Genetics, Epidemiology and Surgery. According to data from OpenAlex, Britt Christensen has authored 90 papers receiving a total of 1.2k indexed citations (citations by other indexed papers that have themselves been cited), including 56 papers in Genetics, 46 papers in Epidemiology and 24 papers in Surgery. Recurrent topics in Britt Christensen's work include Inflammatory Bowel Disease (56 papers), Microscopic Colitis (39 papers) and Eosinophilic Esophagitis (9 papers). Britt Christensen is often cited by papers focused on Inflammatory Bowel Disease (56 papers), Microscopic Colitis (39 papers) and Eosinophilic Esophagitis (9 papers). Britt Christensen collaborates with scholars based in Australia, United States and Canada. Britt Christensen's co-authors include David T. Rubin, Peter R. Gibson, Jonathan M. Erlich, John Hart, Jerrold R. Turner, Olufemi Kassim, Stephen B. Hanauer, Andrés Yarur, Rose Vaughan and Russell D. Cohen and has published in prestigious journals such as Gastroenterology, PLoS ONE and Gut.

In The Last Decade

Britt Christensen

81 papers receiving 1.1k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Britt Christensen Australia 17 804 674 359 146 129 90 1.2k
Camille Zallot France 12 600 0.7× 515 0.8× 295 0.8× 107 0.7× 313 2.4× 20 1.0k
Petra A. Golovics Hungary 19 917 1.1× 763 1.1× 399 1.1× 51 0.3× 69 0.5× 78 1.1k
Selwyn Odes Israel 17 957 1.2× 818 1.2× 411 1.1× 43 0.3× 47 0.4× 27 1.2k
Anna Ramírez‐Morros Spain 12 695 0.9× 521 0.8× 412 1.1× 67 0.5× 65 0.5× 32 1.1k
Bo Vestergaard Pedersen Denmark 9 337 0.4× 264 0.4× 192 0.5× 26 0.2× 183 1.4× 9 1.0k
Kathleen G. Lomax United States 17 1.6k 2.0× 1.3k 1.9× 660 1.8× 49 0.3× 52 0.4× 59 2.0k
J van der Woude Netherlands 7 459 0.6× 315 0.5× 255 0.7× 26 0.2× 65 0.5× 21 804
Jeroen G. Noordzij Netherlands 15 384 0.5× 248 0.4× 257 0.7× 80 0.5× 254 2.0× 29 1.2k
Sarah Persing United States 11 362 0.5× 282 0.4× 404 1.1× 13 0.1× 76 0.6× 42 822
John Lin United States 19 147 0.2× 445 0.7× 728 2.0× 43 0.3× 601 4.7× 57 1.5k

Countries citing papers authored by Britt Christensen

Since Specialization
Citations

This map shows the geographic impact of Britt Christensen's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Britt Christensen with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Britt Christensen more than expected).

Fields of papers citing papers by Britt Christensen

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Britt Christensen. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Britt Christensen. The network helps show where Britt Christensen may publish in the future.

Co-authorship network of co-authors of Britt Christensen

This figure shows the co-authorship network connecting the top 25 collaborators of Britt Christensen. A scholar is included among the top collaborators of Britt Christensen based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Britt Christensen. Britt Christensen is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Etten‐Jamaludin, Faridi S. van, F de Voogd, Britt Christensen, et al.. (2025). P1186 Transperineal ultrasound is accurate in detecting perianal complications in Crohn’s disease: a systematic review and meta-analysis. Journal of Crohn s and Colitis. 19(Supplement_1). i2155–i2156. 3 indexed citations
2.
Rosini, Francesca, Roger Feakins, Paula Borralho, et al.. (2024). DOP01 Definitions of histological abnormalities in inflammatory bowel disease: an ECCO position paper. Journal of Crohn s and Colitis. 18(Supplement_1). i72–i72. 1 indexed citations
3.
Christensen, Britt, et al.. (2024). Long-Term Follow Up of Patients Treated for Inflammatory Bowel Disease and Cytomegalovirus Colitis. Diagnostics. 14(18). 2030–2030. 1 indexed citations
4.
Vernon‐Roberts, Angharad, et al.. (2024). Pediatric to Adult Transition in Inflammatory Bowel Disease: Consensus Guidelines for Australia and New Zealand. Inflammatory Bowel Diseases. 31(2). 563–578. 5 indexed citations
5.
Akiyama, Shintaro, et al.. (2024). Patients with ulcerative colitis who have normalized histology are clinically stable after de-escalation of therapy. Knowledge@UChicago (University of Chicago). 1(1). 1 indexed citations
6.
Feakins, Roger, Paula Borralho, Ann Driessen, et al.. (2023). Definitions of Histological Abnormalities in Inflammatory Bowel Disease: an ECCO Position Paper. Journal of Crohn s and Colitis. 18(2). 175–191. 19 indexed citations
7.
Macrae, Finlay, et al.. (2023). Benefits and Challenges of Treat-to-Target in Inflammatory Bowel Disease. Journal of Clinical Medicine. 12(19). 6292–6292. 9 indexed citations
8.
Christensen, Britt, et al.. (2023). Are We Ready to Reclassify Crohn’s Disease Using Molecular Classification?. Journal of Clinical Medicine. 12(18). 5786–5786. 2 indexed citations
9.
Laube, Robyn, Christian P. Selinger, Cynthia H. Seow, et al.. (2023). Australian inflammatory bowel disease consensus statements for preconception, pregnancy and breast feeding. Gut. 72(6). 1040–1053. 18 indexed citations
10.
Christensen, Britt, et al.. (2023). P636 Real-world clinical effectiveness and safety of vedolizumab and ustekinumab in biologic-naïve patients with Crohn’s disease: Results from the EVOLVE Expansion study. Journal of Crohn s and Colitis. 17(Supplement_1). i768–i769. 2 indexed citations
11.
Solitano, Virginia, David F. Schaeffer, Malcolm Hogan, et al.. (2023). Reliability and Responsiveness of Histologic Indices for the Assessment of Crohn’s Disease Activity. Clinical Gastroenterology and Hepatology. 22(9). 1898–1907.e25. 4 indexed citations
12.
13.
Christensen, Britt, et al.. (2021). Reporting Conflict from Afar: Journalists, Social Media, Communication Technologies, and War. Journalism Practice. 17(2). 300–318. 10 indexed citations
14.
Tjandra, Douglas, Mayur Garg, Corina Behrenbruch, et al.. (2021). Review article: investigation and management of internal fistulae in Crohn’s disease. Alimentary Pharmacology & Therapeutics. 53(10). 1064–1079. 12 indexed citations
15.
Johnson, Douglas, John Halliday, Robert V. Bryant, et al.. (2021). SARS‐CoV‐2 vaccination in patients with inflammatory bowel disease. PubMed. 3(4). 212–228. 8 indexed citations
16.
Christensen, Britt, Stephen B. Hanauer, Peter G. Gibson, et al.. (2020). Segmental Histological Normalisation Occurs in Ulcerative Colitis but Does Not Improve Clinical Outcomes. Journal of Crohn s and Colitis. 14(10). 1345–1353. 12 indexed citations
17.
18.
Narula, Neeraj, et al.. (2020). Histologic remission does not offer additional benefit for ulcerative colitis patients in endoscopic remission. Alimentary Pharmacology & Therapeutics. 52(11-12). 1676–1682. 14 indexed citations
19.
Christensen, Britt, Jonathan M. Erlich, Peter R. Gibson, et al.. (2019). Histologic Healing Is More Strongly Associated with Clinical Outcomes in Ileal Crohn’s Disease than Endoscopic Healing. Clinical Gastroenterology and Hepatology. 18(11). 2518–2525.e1. 62 indexed citations
20.
Christensen, Britt, Peter R. Gibson, Dejan Micić, et al.. (2018). Safety and Efficacy of Combination Treatment With Calcineurin Inhibitors and Vedolizumab in Patients With Refractory Inflammatory Bowel Disease. Clinical Gastroenterology and Hepatology. 17(3). 486–493. 59 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Camille Zallot Breakdown of academic impact, for papers by Petra A. Golovics Breakdown of academic impact, for papers by Selwyn Odes Breakdown of academic impact, for papers by Anna Ramírez‐Morros Breakdown of academic impact, for papers by Bo Vestergaard Pedersen Breakdown of academic impact, for papers by Kathleen G. Lomax Breakdown of academic impact, for papers by J van der Woude Breakdown of academic impact, for papers by Jeroen G. Noordzij Breakdown of academic impact, for papers by Sarah Persing Breakdown of academic impact, for papers by John Lin
Rankless by CCL
2026